$Histogenics(OCGN)$ good dip to buy. Covaxin effective against 3 new mutated variant including india's double mutant. EUA and FDA on the way, once approved we will be positioned near Moderna's market cap if not Novavax. Easy storage, charging 10bucks per vax, 40% net profit deal partnership w India. Imagine the possibilities. This Friday is the day
精彩评论